InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI
InHealth Group and CTI have agreed to jointly develop seven new PET and PET/CT centers in the U.K. and to collaborate in the management of existing InHealth imaging centers to provide PET and PET/CT services. Onsite manufacturing facilities using CTI technology will produce positron radioisotopes, including FDG. The new centers will be established in close collaboration with the U.K.'s major National Health Service trusts and leading academic institutions. Additionally, the two companies will support a U.K.-wide mobile scanning service. Both the mobile service and the first scanning center are already operational, and InHealth has already carried out more than 2000 PET scans. InHealth will utilize CTI's cyclotron and chemistry technology and expertise in the development of new PET tracer production, pharmacy, and distribution facilities.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.